Literature DB >> 6314726

Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility.

M C Viguier-Martinez, M T Hochereau de Reviers, B Barenton, C Perreau.   

Abstract

Adult male Wistar rats were treated with flutamide from 90 to 105 days of age. In a first experiment, testis and accessory sex organs were weighed. In the same animals, hypothalamic LRH content, pituitary gonadotrophin concentrations, plasma LH, FSH, prolactin and testosterone levels, and testicular gonadotrophin receptors were evaluated. In a second experiment, fertility was tested at the end of the treatment, and histology of the testis was performed. All the results were compared to those obtained in control animals of the same age. Accessory glands of genital tract were significantly lower in flutamide-treated animals (P less than 0.01). Hypothalamic LRH, pituitary and plasma FSH, and prolactin concentrations were unchanged, while pituitary and plasma LH level and especially plasma testosterone concentration were increased (P less than 0.001). Flutamide therefore exerted a strong inhibition on testosterone-dependent organs, and blocked the negative feedback of testosterone on the hypothalamo-pituitary axis, increasing the LH levels. Testis weight, intertubular tissue volume, total number and total volume of Leydig cells/testis, as well as total length and diameter of seminiferous tubules were unchanged in flutamide treated rats. However number of LH receptors/Leydig cell, nuclear area of Sertoli cells, number of FSH receptors/Sertoli cell, number of leptotene spermatocytes and of round spermatids per cross section, and yield of spermatogonial divisions were decreased after treatment. Flutamide treatment also decreased fertility by 48% (P less than 0.05). This lowered fertility is likely the result of impaired spermatogenesis and/or a dysfunction of accessory sex organs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314726     DOI: 10.1530/acta.0.1040246

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Assessing the antiandrogenic properties of propyl paraben using the Hershberger bioassay.

Authors:  Ecem Özdemir; Nurhayat Barlas; Mehmet Alper Çetinkaya
Journal:  Toxicol Res (Camb)       Date:  2018-01-25       Impact factor: 3.524

2.  Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.

Authors:  Tomoharu Shimizu; Huang-Ping Yu; Ya-Ching Hsieh; Mashkoor A Choudhry; Takao Suzuki; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

3.  Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.

Authors:  Kayla J Renier; Sandra M Troxell-Smith; Jamie A Johansen; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; Jason P Chua; Hong Sun Kim; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Endocrinology       Date:  2014-04-17       Impact factor: 4.736

4.  Flutamide Alters the Expression of Chemerin, Apelin, and Vaspin and Their Respective Receptors in the Testes of Adult Rats.

Authors:  Malgorzata Brzoskwinia; Laura Pardyak; Agnieszka Rak; Alicja Kaminska; Anna Hejmej; Sylwia Marek; Malgorzata Kotula-Balak; Barbara Bilinska
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.